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Using gene-specific synthetic oligonucleotides the 
expression and regulation of kallikrein-like genes in 
the human prostatic cancer cell line LNCaP were 
studied. Prostate-specific antigen (PSA) and human 
glandular kallikrein (hGK-1) together constitute a 
subfamily of serine proteases exclusively produced 
in the human prostate. RNA analysis revealed that 
both genes are expressed in LNCaP cells with PSA 
basal levels being 2-fold higher than hGK-1 levels. 
Both mRNAs are induced over a period of 24 h in 
the presence of 3.3 nM of the synthetic androgen 
mibolerone. Stimulation of PSA RNA is about 5- 
fold,whereas hGK-1 stimulation is less pronounced. 
Nuclear run-on analysis revealed that androgen in- 
duction of kallikrein-like genes in LNCaP cells is a 
rapid event (c3 h) occurring at the level of transcrip- 
tion initiation. Treatment of cells with cycloheximide 
demonstrates that, while PSA/hGK-1 basal tran- 
scription strictly depends on continuous protein syn- 
thesis, transcriptional induction by androgen does 
not. This suggests the direct involvement of the 
androgen receptor in the induction process inde- 
pendent of additional labile protein factors neces- 
sary for kallikrein basal transcription. A binding motif 
is present in the PSA and hGK-1 promoters, closely 
resembling the consensus sequence for steroid- 
responsive elements. The androgen antagonist cy- 
proterone acetate was also able to stimulate tran- 
scription of kallikrein-like genes in LNCaP cells. In 
contrast, androgen-dependent transcriptional 
suppression of the protooncogene c-myc was 
strongly counteracted by cyproterone acetate. Thus, 
antiandrogens act differentially on androgen-regu- 
lated prostate-specific (PSA, hGK-1) and growth- 
related (c-myc) gene expression in LNCaP cells. 
(Molecular Endocrinology 6: 753-762,1992) 
INTRODUCTION 
Activation of gene expression by extracellular stimuli 
often requires a multistep signal transduction pathway. 
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Typically, an external signal molecule binds specifically 
to a receptor which releases a second messenger into 
the cytosol, leading to signal transformation and trans- 
duction into the nucleus, ultimately resulting in the 
activation of responsive genes. Ligand-inducible tran- 
scription factors of the steroid and thyroid hormone 
receptor superfamily are unique among transcription 
activators in that they combine each of these steps in 
a single molecule. The steroid hormone-receptor com- 
plex formed in the cytosol undergoes a conformational 
change induced by hormone binding and dissociation 
from heat shock protein 90 and translocates into the 
nucleus where it binds to specific recognition se- 
quences near the promoter of the gene to be activated 
(for review see Refs. l-3). The present study charac- 
terizes some aspects of steroid hormone regulation of 
two androgen-dependent genes from the human pros- 
tate. 
Prostate-specific antigen (PSA) and human glandular 
kallikrein (hGK-1) belong, together with kidney/pan- 
creas kallikrein (4, 5) to the subfamily of kallikrein-like 
serine proteases (for review see Ref. 6). The 34-kilo- 
dalton PSA glycoprotein (7, 8) which has a chymotryp- 
sin-like specificity (9) was reported to cleave semino- 
gelin, a major seminal vesicle protein responsible for 
the gel-like structure of semen (10,ll). The appearance 
of PSA in male serum is diagnostic of destruction of 
tissue boundaries by prostatic neoplasms and corre- 
lates well with tumor progression and the patients’ 
prognosis (12, 13). hGK-1 may be a typical kininogen- 
processing enzyme (6). Its precise function in prostate 
physiology remains to be elucidated. 
PSA and hGK-1 expression has been demonstrated 
in human prostate only, and consequently PSA cDNA 
was cloned from benign and malignant prostatic tissue 
by several groups (14-l 6). The hGK-1 gene was iso- 
lated by screening a human genomic library with a 
mouse kallikrein gene fragment (17). Chromosome 
mapping showed that both genes are tandemly located 
in the same orientation on chromosome 19 (18). As the 
gene for kidney/pancreas kallikrein has also been as- 
signed to chromosome 19 (19) this suggests a com- 
mon ancestor of kallikrein-like genes in evolution. Se- 
quence comparison revealed a close relationship be- 
tween PSA and hGK-1 in exonintron architecture with 
an overall homology of 82% (20, 21). The promoter 
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regions also exhibit a high degree of homology and 
contain, within 200 base pairs (bp), several well known 
cis-regulatory elements which have been defined by 
sequence homology only (20, 21). These include a 
variant TATA box, a transcription factor Spl binding 
site, and a CACCC motif. A 15bp imperfect palindrome 
closely resembling the consensus sequence for nuclear 
steroid receptor binding sites (1) resides upstream of 
the transcription start site at positions -155 to -170 
of the published genomic sequences of both PSA and 
hGK-1 (21-23). 
In recent publications we and others (24-27) have 
demonstrated androgen-dependent induction of PSA- 
related steady state mRNA in the androgen receptor- 
containing human prostatic cancer cell line LNCaP. In 
the present study we have used this cell line, which is 
the best suited in vitro model of prostate cancer avail- 
able (28, 29) to study the androgen dependence of 
kallikrein-like genes in greater detail. By specific oligo- 
nucleotide hybridization and nuclear run-on analysis we 
show that both genes, PSA and hGK-1, are induced by 
androgen at the level of transcription initiation. This is 
the first demonstration of direct androgen induction of 
kallikrein genes. 
RESULTS 
Stimulation of PSA-Related mRNA by Androgen 
To monitor the time course of PSA steady state RNA 
induction, LNCaP cells were treated for increasing pe- 
riods of time with 3.3 nM of the nonmetabolizable 
synthetic androgen mibolerone (MIB; 7cu,l7a-dimethyl- 
19-nortestosterone) (30) to provide a constant andro- 
genie stimulus to the cells. This concentration of syn- 
thetic androgen has proven to be maximally effective in 
stimulating the LNCaP androgen receptor (31). Isolated 
RNAs were subjected to Northern analysis by hybridi- 
zation with a PSA cDNA probe (15, 24). As shown in 
Fig. 1 A, the level of PSA mRNA, with an expected size 
of 1.5 kilobases (kb), rises continuously within 4-72 h 
after hormone addition. Maximal induction is lo-fold 
after 72 h as compared to control levels simultaneously 
determined in the absence of MIB (Fig. 1 B). Note that 
the time scale in Fig. 18 is not linear. The additional 
bands seen in Fig. 1 A are likely to represent alternatively 
processed kallikrein transcripts, as has been described 
(18). The housekeeping enzyme glyceraldehyde-phos- 
phate-dehydrogenase (GAPDH) is not significantly influ- 
enced by MIB (32), and the corresponding mRNA can 
thus be used to correct for changes in hybridization 
signal due to differences in the amounts of RNA loaded 
on the gel. 
Comparison of Androgen Effects on PSA and hGK- 
1 Expression 
Due to the high degree of homology in the coding 
regions of the PSA and hGK-1 genes, hGK-1 mRNA 
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Fig. 1. Northern Blot Analysis of Total RNA of LNCaP Cells 
after Treatment with the Synthetic Androgen MIB 
A, LNCaP cells were cultivated in the presence (+) or 
absence (-) of 3.3 nM MIB for various periods from O-72 h. 
RNA was extracted and analyzed on Northern blots (20 pg/ 
lane) and hybridized with a PSA EcoRI/BamHl cDNA probe 
labeled by random priming. Subsequently the probe was 
washed off, and the filter was rehybridized with a probe for 
the housekeeping enzyme GAPDH (72). B, The autoradi- 
ograms were scanned densitometrically, and the results of 
PSA hybridization relative to GAPDH are shown schematically 
in a block diagram. 
might contribute considerably to the Northern blot sig- 
nal obtained with a PSA cDNA probe (6,33). To explore 
whether both prostatic kallikrein genes are regulated 
by androgen, we synthesized oligonucleotides which 
were recently shown to be able to discriminate between 
PSA and hGK-1 in primer extension experiments (33). 
The slot blot hybridization in Fig. 2A shows that both 
genes, PSA and hGK-1, are expressed in LNCaP cells. 
In unstimulated control cells (time points 0, 24, 48, and 
72 h in the absence of MIB) the level of PSA messenger 
exceeds the level of hGK-1 mRNA by a factor of 2. 
Greater abundance of PSA RNA compared to hGK-1 
RNA has also been noticed in benign prostate hyper- 
plasia (33). Both mRNAs increase within 72 h after 
hormone addition (for a quantitative assessment see 
densitometer scan in Fig. 28). However, hGK-1 induc- 
tion by MIB is less pronounced compared to PSA 
induction in LNCaP cells. The signal obtained by hybrid- 
ization against PSA cDNA reveals the specificity of the 
oligonucleotides used (Fig. 2A, top). These results show 
that, in LNCaP cells, both prostatic kallikrein genes are 
positively regulated by androgen. 
Androgen Induction of PSA-related Genes Takes 
Place at the Level of Transcription Initiation 
PSA-related mRNAs progressively increase from 4-72 
h in LNCaP cells upon androgen administration. The 
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Fig. 2. Slot Blot Analysis of LNCaP RNA Showing the Andro- 
gen Dependence of PSA and hGK-1 
A, Five micrograms of the same RNAs as described in Fig. 
1 were transferred to nylon membranes using a commercial 
manifold and probed with equal amounts of PSA- and hGK-l- 
specific oligonucleotide probes labeled by polynucleotide ki- 
nase. B, Densitometer scan of PSA and hGK-1 hybridization 
signals normalized to the GAPDH signal (r = PSA/GAPDH or 
hGK-l/GAPDH) obtained by rehydridization with a GAPDH- 
specific probe (autoradiograms not shown). 
early onset of RNA induction could reflect a direct effect 
of MIB on gene transcription. To test this hypothesis 
we performed nuclear run-on analyses to measure the 
androgen dependence of the density of actively tran- 
scribing polymerase II molecules on PSA-related genes. 
Double-stranded and single-stranded PSA cDNA frag- 
ments presumably recognizing both PSA and hGK-1 
RNA were immobilized on nylon filters and hybridized 
with 32P-labeled transcripts isolated from nuclei of 
LNCaP ceils treated for different periods with MIB. 
Probes for the phospho-glycerate kinase gene (PGK) 
and the c-myc gene which is negatively regulated by 
androgen (32) were used as internal controls. As shown 
in Fig. 3, PSA/hGK-1 transcription is e-fold induced by 
MIB. Significant transcription is only detectable on the 
coding strand of the PSA/hGK-1 genes. Peak induction 
is observed between 3-12 h after hormone addition. 
hrs 
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Fig. 3. Transcriptional Run-On Activity of PSA-Related Genes 
and c-myc in MIB-Treated LNCaP Cells 
A, Plasmids containing double-stranded and single-stranded 
DNA probes were transferred to nylon membranes by slot blot 
and hybridized with nuclear run-on RNA (10’ cpm/3 ml hybrid- 
ization buffer) from LNCaP cells treated without (0 h) or with 
MIB for 3-48 h. The PSA probe cloned in both orientations in 
Ml 3 phages was a 1.5-kb EcoRl cDNA fragment encompass- 
ing the complete coding sequence for the mature PSA protein. 
The PSA probe 29/l 1 was an approximately 780-bp EM/&cl 
fragment, spanning 580 bp of the second intron and 200 bp 
of the third exon (23). The c-myc inset-l was a 1.4-kb EcoRI/ 
CM cDNA fragment cloned in pBR 328 containing parts of the 
third exon (32). The PGK plasmid contains a 1.8-kb EcoRl 
cDNA fragment cloned in pBR 322 (24). B, Autoradiograms 
were scanned densitometrically, normalized to the PGK signal, 
and results are shown relative to basal transcription levels in 
untreated control cells. 
From 24-48 h PSA/hKG-1 transcription slowly returns 
to pretreatment levels (Fig. 38). This may be due to 
autologous down-regulation of the androgen receptor 
after hormone stimulation (25,34). While PGK transcrip- 
tion remains almost stable during the course of the 
experiment, c-myc gene transcription slowly decreases 
concomitantly to androgen-induced reduction of cell 
proliferation as has been reported earlier (24, 32). 
Contribution of Posttranscriptional Mechanisms to 
Hormonal PSA/hGK-1 Regulation 
The kinetics of PSA/hGK-1 induction in Northern blots 
and run-on assays are somewhat different in that max- 
imal induction of steady state RNA is achieved at time 
points when transcription already decreases again. We 
therefore attempted to evaluate the possible participa- 
tion of posttranscriptional regulation. In the absence of 
MIB, PSA/hGK-1 RNA half-life was approximately 24 h 
(Fig. 4). In the presence of MIB (72 h), PSA/hGK-1 RNA 
levels showed some variability in response to treatment 
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Fig. 4. Half-Lives of PSA/hGK-1 RNA in the Absence and 
Presence of MIB 
A, Untreated LNCaP cells and cells treated with MIB for 72 
h were incubated for various periods from O-24 h with acti- 
nomycin D (5 @g/ml), and RNA was isolated and subjected to 
Northern analysis by hybridization with a PSA cDNA probe. B, 
Autoradiograms were scanned, and results are shown relative 
to PSA/hGK-1 levels obtained at the time point 0 h after 
actinomycin D treatment. 
with actinomycin D for different periods but were still 
90% of untreated control levels 24 h after actinomycin 
D administration (Fig. 48). The high stability of PSA/ 
hGK-1 RNA in MIB-induced cells precluded the exact 
determination of its half-life by conventional treatment 
of cells with actinomycin D. Nevertheless, the low deg- 
radation rate of PSA/hGK-1 RNA explains quite well 
the ongoing accumulation of transcripts several hours 
after transcriptional induction has occurred. These re- 
sults indicate an involvement of posttranscriptional 
mechanisms in the hormonal PSA/hGK-1 induction 
process. 
Androgen induction of PSA/hGK-1 Transcription is Effect of Antiandrogen on PSA and hGK-1 
Independent of Protein Synthesis Expression 
To establish whether protein synthesis is required for The time course of the run-on analysis strongly sug- 
the immediate induction of kallikrein gene expression, gests that the early androgen-dependent induction of 
we carried out run-on transcription in nuclei from cells PSA-related mRNA is a direct hormone effect on gene 
treated with the protein synthesis inhibitor cyclohexim- expression, presumably involving the androgen recep- 
ide (CHX) for 6 h. Figure 5 again shows PSA/hGK-1 tor (AR). In order to explore the possible participation 
induction by MIB. However, PSA/hGK-1 basal tran- of the AR we tried to antagonize the effect of MIB by 
scription strictly depends on newly synthesized pro- the AR antagonist cyproterone acetate (CA). Due to the 
teins. Only a few elongated transcripts are detectable relatively low affinity of CA to the AR a more than 500- 
after CHX treatment for 6 h. Note that the transcription fold molar excess (1.8 PM) over the androgen is required 
rates for the human androgen receptor (hAR) gene and for efficient blockage of androgen action (35). The 
the PGK gene are not significantly affected by CHX. Northern blots in Fig. 6 hybridized with PSA- and hGK- 
Simultaneous administration of CHX + MIB restores l-specific oligonucleotides show the effect of MIB and 
transcriptional activity nearly to the level observed in CA on kallikrein-like mRNAs in LNCaP cells. Again an 
+ + MI6 
+ + CHX 
B fold transcription 
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Fig. 5. Effect of Inhibition of Protein Synthesis on PSA/hGK-1 
Transcription 
A, Filters prepared as described in Fig. 3 were hybridized 
with nuclear run-on RNA of LNCaP cells treated with MIB (+/ 
- MIB) and with 10 pg/ml of the protein synthesis inhibitor 
CHX (+/- CHX) for 6 h. The hAR cDNA probe contained 
within a eukaryotic expression plasmid (74) spans the com- 
plete coding region for the human androgen receptor protein 
(kindly provided by Dr. J. Trapman). B, Autoradiograms were 
scanned, and results are shown as in Fig. 3. 
untreated control cells (Fig. 5B). The magnitude of the 
induction effect of MIB in the presence of CHX (= 2.5x) 
compared to cells treated with CHX alone is equal to 
the induction observed by MIB alone compared to 
untreated control cells (= 2.2x). These results demon- 
strate that PSA/hGK-1 basal transcription but not in- 
duction by MIB is dependent on the ongoing synthesis 
of a labile protein factor. 
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Fig. 6. Northern Blot Analysis of RNA of LNCaP Cells Treated 
with the Synthetic Androgen MIB and the Antiandrogen CA 
LNCaP cells were maintained in the presence (+) or absence 
(-) of 3.3 nM MIB and 1.8 PM CA for 48 h. RNA was isolated 
and analyzed on Northern blots (20 pg/lane) with PSA- and 
hGK-1 -specific oligonucleotides as in Fig. 2. RNA of the human 
promyelocytic cell line HL 60 was used as a control for 
hybridization specificity. Filters were reprobed with GAPDH to 
document equal loading of RNA per lane. 
increase in signals corresponding to the mol wt of PSA 
and hGK-1 mRNA (both 1.5 kb) is distinctly detectable 
in LNCaP cells 48 h after MIB treatment, but not in the 
promyelocytic cell line HL 60. Unexpectedly, CA alone 
also stimulates PSA and hGK-1 expression. The stim- 
ulator-y potency of 1.8 /IM CA is equivalent to 3.3 nM 
MIB. However, combined administration of MIB and CA 
reveals no antagonistic activity. 
Fig. 7. Differential Effect of the Antiandrogen CA on PSA/hGK- 
1 and c-myc Expression 
The Northern blots shown in Fig. 6 were reprobed with a 
PSA cDNA and a c-myc cDNA probe specific for the third exon 
labeled by random priming. 
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Differential Effect of Antiandrogen on PSA/hGK-1 
and c-myc Expression 
In previous work (24) we have already demonstrated 
that 1.8 FM CA potently antagonizes the effect of 3.3 
nM MIB on the proliferation of LNCaP cells, while not 
having any effect when administered alone. To resolve 
further the unexpected agonism of antiandrogen on 
androgen-dependent gene expression, we compared 
the effect of CA on kallikreins with its effect on c-myc, 
a gene known to be involved in growth regulation. The 
same filters as in Fig. 6 were reprobed with PSA cDNA 
and a third exon probe of the human c-myc gene. As 
shown in Fig. 7, steady state RNA of c-myc is sup- 
pressed by MIB, while PSA/hGK-1 RNA is increased. 
However, whereas in the case of PSA/hGK-1 , antian- 
drogen has a considerable androgen agonistic effect, 
in the case of c-myc the androgen-induced repression 
of steady state RNA is fully overcome by the simulta- 
neous addition of CA (Fig. 7, lanes +MIB and +CA). 
CA alone has, in contrast to PSA/hGK-1 , no effect on 
c-myc expression and therefore behaves as a true 
androgen antagonist. 
To investigate whether agonistic action of antiandro- 
0 MI6 1 MWCA 1 CA 
1 PSAlPGK 1 1 I 2.2 I 1.9 2.1 
I  
= PSAlPGK 
Fig. 6. Effect of CA on PSA/hGK-1 Transcription 
A, Identical filters as described in Fig. 5. were hybridized 
with run-on RNA of LNCaP cells treated with (+) or without 
(-) 3.3 nM MIB and/or 1.8 FM CA for 6 h. B, Autoradiograms 
were scanned, and results are shown as described in Fig. 3. 
gen on PSA/hGK-1 expression also takes place at the 
level of transcription, we performed nuclear run-on ex- 
periments in the presence of CA and CA + MIB, re- 
spectively. As shown in Fig. 8A, CA induces PSA/hGK- 
1 transcription, nearly to the same extent as MIB. 
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Simultaneous administration of CA plus MIB also in- 
creases PSA/hGK-1 transcription but does not result in 
overstimulation (Fig. 8B). These results establish that 
the androgen agonism of CA on kallikrein gene expres- 
sion in LNCaP cells is mediated by the same transcrip- 
tional induction pathway as the effect of MIB. 
DISCUSSION 
Thus far, expression and regulation of kallikrein genes 
have been extensively studied only in rodents. The 
kallikrein gene families of rat and mouse are probably 
much larger than that of man (6) consisting of 24 
members in the mouse (36, 37) and 8-17 members in 
the rat (38, 39). Rodent kallikrein genes have been 
shown to be subject to complex tissue-specific (39, 40) 
and hormonal (41-43) regulatory mechanisms. Regu- 
lation of kallikrein protein synthesis and steady state 
RNA levels by androgens has also been observed (44- 
46). Expression of mouse kallikrein genes mGK-3, 4, 
and 5 was shown to be induced by testosterone in the 
salivary gland (45). In the rat prostate, kallikrein S3 and 
Pl mRNAs disappeared 8 days after castration and 
were restored to control levels by dihydrotestosterone 
administration for 8 days (46). However, both re- 
sponses are slow and thus imply that androgens are 
not necessarily acting directly on rodent kallikrein genes 
(45, 46). Immediate transcriptional regulation of kalli- 
krein expression has thus far only been noticed in the 
rat pituitary by dopamine (47). In contrast, the results 
shown in the present study demonstrate that, unlike in 
rodents, regulation of the human kallikrein-related PSA 
and hGK-1 genes by androgen in LNCaP cells occurs 
primarily at the level of transcription initiation, presum- 
ably involving the androgen receptor. Note however 
that these results do not rule out the possibility that still 
unidentified members of the presumably larger human 
kallikrein gene family contribute to the hybridization 
signal obtained with the full length PSA cDNA probe 
used in the run-on transcription assays. 
Several gene fragments have definitely been shown 
to act as androgen-dependent enhancers of transcrip- 
tion. These are the long terminal repeat of mouse 
mammary tumor virus (48) an upstream element of the 
mouse sex-limited protein gene (49) and a part of the 
first intron of the rat prostatic binding protein gene, 
C3[1] (50). The sequence 5’-AGTACGTGATGTTCT-3’ 
contained within the C3[1] gene was shown to confer 
androgen inducibility onto a heterologous promoter (50) 
and to specifically bind a bacterially expressed chimeric 
androgen receptor (51). The PSA promoter also harbors 
a partially palindromic 15-bp stretch closely resembling 
the above androgen response element of the rat (21, 
23). The sequence 5’-AGCACTTGCTGTTCT-3’ occur- 
ring in the PSA promoter at positions -155 to -170 of 
the noncoding strand differs in the hGK-1 promoter in 
only one base at position -170 (TG). Although prelimi- 
nary studies have revealed the binding of a nuclear 
protein to the PSA sequence in gel shift experiments 
(Wolf, D. A., unpublished observation), it is at present 
unknown whether this element mediates the transcrip- 
tional regulation of PSA/hGK-1 by androgen. Further 
investigations are required to verify this speculation and 
the possibility that additional sequences present in the 
PSA/hGK-1 promoters, namely the Spl binding site 
and the CACCC motif, contribute to PSA regulation, 
since these elements have recently been shown to 
cooperate with steroid hormone response elements 
(52). 
The finding that protein synthesis is dispensible for 
the induction of PSA/hGK-1 transcription in LNCaP cells 
confirms Northern blot data provided by Young et al. 
(27). However, these workers have found superinduc- 
tion of PSA steady state RNA by MIB in the simulta- 
neous presence of CHX. Thus CHX appears to drasti- 
cally stabilize PSA RNA while decreasing PSA/hGK-1 
basal level transcription (Fig. 5). Unfortunately the effect 
of CHX alone on PSA steady state RNA expression 
was not investigated. Taking into account that CHX 
might further increase the stability of PSA RNA, which 
is exceptionally stable anyway, it appears questionable 
whether the inhibiting effect of CHX on PSA/hGK-1 
basal level transcription could be detected in Northern 
blot analyses. Regulation by steroid hormones inde- 
pendent of protein synthesis has been observed for 
several genes in various cell types (53-56). In most 
cases this has been interpreted to reflect direct gene 
induction via the homologous hormone receptor. Thus 
our CHX data lend further support to the concept that 
androgen induction of prostate kallikrein gene transcrip- 
tion is mediated by the AR. 
Our results demonstrating differential effects of the 
antiandrogen CA on prostate-specific and growth-re- 
lated gene expression in LNCaP cells raise some inter- 
esting questions on gene regulation by androgens. 
While CA antagonizes androgen suppression of c-myc 
transcription, it does not antagonize androgen induction 
of PSA/hGK-1 and even has androgen agonistic activity 
on kallikrein transcription (Figs. 7 and 8). 
An important aspect of antiandrogen action in LNCaP 
cells is given by the recent publication of a point muta- 
tion in the androgen receptor gene in LNCaP cells, 
which results in a single amino acid substitution (ThrAla) 
in the steroid binding domain (31). By amplification with 
the polymerase chain reaction and sequence analysis 
of this region we have recently confirmed this mutation 
in our stock of LNCaP cells (data not shown). This 
alteration in receptor structure was shown to cause 
both increased affinity for progestins (57) and receptor- 
mediated inducibility of a glucocorticoid/progestin re- 
sponse element by CA (31). Since the wild type receptor 
was unable to respond to CA (31). the androgen agon- 
ism of CA on PSA/hGK-1 transcription observed in 
LNCaP cells could be a special feature of the mutated 
receptor in these cells. However, this interpretation 
alone is not sufficient to explain the differential effect of 
CA on PSA/hGK-1 vs. c-myc. 
In general, the mechanisms of antihormone action on 
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hormone-responsive genes are not completely under- 
stood, although several have been proposed (58, 59). 
For, example the effects of the antiestrogen 4-hydroxy- 
tamoxifen have been shown to vary greatly with the 
species, tissues, cells, and response being studied (for 
review see Refs. 60-62). 4-Hydroxy-tamoxifen has vari- 
able activity, ranging from full estrogenic to totally an- 
tiestrogenic activity, for the induction of a number of 
RNA species in cultured breast cancer cells (63-65). 
These results emphasize the marked cell-type and pro- 
moter-context dependence of antihormone action. 
The action of antiandrogens on gene expression is 
much less well documented. Recent studies have 
shown that the antiandrogen CA can have considerable 
androgen agonistic activity on the expression of andro- 
gen-regulated genes (34, 66). Androgen antagonism of 
CA has also been demonstrated on the androgen- 
induced suppression of the nerve growth factor recep- 
tor gene in rat testis (67). Our results from LNCaP cells 
show that CA can have androgen-agonistic as well as 
-antagonistic activity even within one cell type. At pres- 
ent the reasons for this discrepancy are not understood. 
As the receptor mutation clearly cannot be responsible 
for both effects, alternative mechanisms may be oper- 
ative. 
Although both PSA-related genes and the c-myc 
gene are regulated by androgen at the level of transcrip- 
tion they differ in several notable aspects: 1) c-myc 
RNA has an exceptionally short half-life of 20 min (68) 
and encodes a nuclear protein which has been impli- 
cated in growth regulation (for review see Refs. 69, 70), 
while, at least, authentic PSA encodes a secretory 
protein, the corresponding RNA of which has a half-life 
of approximately 24 h (Fig. 4); 2) PSA-related genes 
are positively regulated by androgen, whereas c-myc is 
negatively regulated (32); and 3) whereas regulation of 
PSA transcription is a rapid event taking less than 3 h 
until maximal induction has occurred, maximal c-myc 
down-regulation is slow (>48 h; Ref. 32 and Fig. 3). It 
is therefore reasonable to assume that the differential 
effect of CA reflects differential mechanisms of andro- 
gen action on gene regulation, possibly depending on 
additional regulatory steps and the particular position 
of the regulated gene in the functional context of the 
whole cell. 
Although the detailed mechanism of the differential 
effects of CA on tissue-specific and growth-related 
gene expression in LNCaP cells cannot be fully as- 
sessed at present, their consideration may offer future 
directions to a more complete understanding of gene 
regulation by androgens. 
MATERIALS AND METHODS 
Cell Culture and Hormones 
The human prostate cancer cell line LNCaP (28) was from the 
Human Cancer Cell Laboratory, Sloan Kettering Institute for 
Cancer Research (Rye, NY). LNCaP cells between passages 
70 and 80 were used for the experiments described. Cells 
were maintained in RPM1 1640 as monolayers in the presence 
of 10% fetal calf serum and 2 mM glutamine as described (24). 
For the preparation of seed stocks, cells were grown to 50- 
75% confluency before use. Hormones were added 48 h after 
seeding as ethanol solutions. Final concentrations of the hor- 
mones were 3.3 nM for the synthetic androgen MIB (Upjohn, 
Kalamazoo, Ml) and 1.8 PM for the antiandrogen CA (Schering 
AG, Berlin, Germany). The protein synthesis inhibitor CHX 
(Sigma, St. Louis, MO) was used at a concentration of 10 pg/ 
ml and actinomycin D (Boehringer Mannheim, Mannheim, Ger- 
many) at a concentration of 5 pg/ml. 
RNA Extraction and Northern Blot Analysis 
Total cellular RNA was isolated by the LiCl/urea method 
described in detail elsewhere (24). RNA samples (20 kg/lane) 
were fractionated on 1.2% agarose gels containing 6% form- 
aldehyde. Integrity and relative amounts of RNA per lane were 
checked by staining with ethidium bromide. 28s and 18s 
rRNAs were used as internal size markers. Gels were blotted 
onto Biodyne nylon membranes (PALL, Glen Cove, NY) and 
baked for 2 h in a vacuum oven. Filters for hybrization with 
cDNA probes were prehybridized in 5-fold concentrated stand- 
ard saline citrate (SSC; 1 x SSC = 150 mM NaCI, 15 mM Na3- 
citrate, pH 7.0) 0.5% sodium dodecyl sulfate (SDS), 1 x Den- 
hardt’s solution, and hybridization was carried out for 20 h at 
68 C in 5 ml of the same solution containing 1.5 x 1 O6 cpm/ 
ml of the respective cDNA probe. Filters were washed at 68 
C once in 4x. SSC, 0.5% SDS, 1 x Denhardt’s solution for 30 
min. twice for 15 min in 2x SSC. 0.5% SDS. 30 min in 2x 
SSC, and subsequently exposed overnight at -80 C to Fuji 
(Tokyo, Japan) x-ray films between intensifier screens. Auto- 
radiograms were scanned in an LKB UltraScan XL Laser 
Densitometer (LKB, Bromma, Sweden). 
Hybridization Probes 
32P labeling was performed with the random-primed labeling 
kit (Boehringer Mannheim) according to the recommendations 
of the supplier. The 1.4-kb EcoRI/BamHI cDNA fragment used 
as a PSA probe (15) spans the coding region of the complete 
mature PSA protein. The c-myc probe was a 1.4-kb EcoRI/ 
C/al fragment covering the third exon (71) and the probe for 
the housekeeping enzyme glyceraldehyde-phosphate-dehy- 
drogenase was a synthetic single-stranded oligonucleotide 
(100 bases) derived from the published sequence (72). The 
oligonucleotides specific for PSA (5’-TTCTGAGGGTGA- 
ACTTGCGCA-3’) and hGK-1 (5’~CTTCTCAGAGTA- 
AGCTCTAGC-3’) were derived from sequences coding for 
amino acids 161-l 67. These oligonucleotides have recently 
been shown to be able to discriminate between PSA and hGK- 
1 in primer extension assays (33). The hybridization tempera- 
ture was determined according the specific oligonucleotide 
content by the formula: T,(‘C) = 4(G + C) + 2(A + T) -3. 
Filters were prehybridized in 6x SSC, O,l% SDS, lx Den- 
hardt’s solution, and 50 pg/ml denatured salmon sperm DNA 
for 2 h at 57 C and hybridized overnight in the same solution 
containing equal amounts (1.5 x 1 O6 cpm/ml) of PSA or hGK- 
1 oligonucleotide probe labeled to a specific activity of 6 x 10’ 
cpm/pg with polynucleotide kinase. Filters were washed in 4x 
SSC, 0.1% SDS for 30 min at 57 C and twice for 15 min in 
2x SSC at 40 C. Autoradiography was carried out for 48 h as 
described above. 
Nuclear Run-On Analysis 
Preparation of nuclei and hybridization were performed as 
described (32). Cells (2 x 10’) were scraped from the culture 
dishes and washed twice in PBS. Cells were resuspended in 
10 mrv Tris-HCI, pH 7.4, 10 mM NaCI, 3 mM MgCl*, and 0.5% 
(vol/vol) NP40, and incubated on ice for 5 min. The nuclear 
pellets were spun down at 500 x g and washed by resuspen- 
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sion in 10 ml of the same buffer. The pelleted nuclei were 
resuspended in storage buffer (50 mM Tris-HCI, pH 8.3, 40% 
(vol/vol) glycerol, 5 mM MgCI,, 0.1 mM EDTA) and frozen in 
liquid nitrogen in portions of 100 ~1 corresponding to 2 x 10’ 
nuclei. For nuclear run-on assays the nuclei were mixed with 
100 PI reaction buffer [lo mM Tris-HCI, pH 8.0, 5 mM MgCI,, 
300 mM KCI, 0.5 mM ATP, CTP, and GTP, and 100 &i [a- 
32P]uTP (800 Ci/mmol; Du Pont, Wilmington, DE)] and incu- 
bated for 20 min at 28 C. DNAse I was added to a final 
concentration of 10 pg/ml, and the incubation was continued 
for 5 min at 28 C. After addition of 200 ~.rl STE buffer (100 mM 
Tris-HCI, pH 7.5, 50 mM EDTA, and 0.5% SDS) and 200 @I 
proteinase K (10 mg/ml, preincubated at 37 C for 1 h) the 
samples were incubated for 1 h at 40 C. Nuclear transcripts 
were separated from unincorporated nucleotides on a Sepha- 
dex G-50 column equilibrated with 10 mM Tris-HCI, pH 7.5, 1 
mM EDTA, and 1% SDS. The labeled RNA was boiled for 10 
min, chilled on ice, and hybridized to DNA probes immobilized 
on Biodyne nylon membranes in Church buffer (0.5 M sodium 
phosphate, pH 7.1, 7% SDS, and 0.1 mM EDTA) (73) after 
preincubation of the filters in the same buffer. After hybridiza- 
tion the filters were washed twice at 50 C in 0.1x SSC, 1% 
SDS, once in 2x SSC containing 10 fig/ml RNase A at 25 C, 
and finally twice again in 0.1~ SSC, 1% SDS at 50 C. The 
filters were exposed for 24-48 h to Fuji X-ray films using a 
DuPont Lightning Plus intensifying screen. 
All run-on assays were repeated at least twice with inde- 
pendent preparations of cell nuclei in order to document repro- 
ducibility. 
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